Ecopipam is a first-in-class investigational small-molecule therapy that selectively blocks dopamine-1 (D1) receptors. It is not an antipsychotic. This mechanism differs from currently approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results